SAN FRANCISCO, May 19, 2025 /PRNewswire/ — At the American Thoracic Society (ATS) Annual Conference, Vitalograph and Thorasys announced a strategic partnership that further integrates oscillometry technology into Vitalograph’s respiratory diagnostics portfolio.
This partnership marks a significant step forward in making advanced respiratory diagnostics more accessible and integrated for healthcare providers and their patients.
Doreen Miao, Vice President of Marketing and Strategic Development at Thorasys, commented: “We are thrilled to launch the tremoflo® C2, our second-generation clinical oscillometry solution, a vital enhancement to PFT testing. Oscillometry facilitates early detection, frequent monitoring and treatment optimization for a broad range of respiratory diseases. And because it’s effort-free testing, it is especially beneficial for patients who find spirometry challenging.”
Seamless Integration for U.S. Respiratory Healthcare Providers
The Thorasys partnership enables Morgan Scientific, Vitalograph’s U.S. entity specializing in pulmonary function testing (PFT) solutions, to offer oscillometry alongside its established suite of respiratory diagnostics. This integration ensures that oscillometry becomes a routine part of respiratory care, enabled by Morgan Scientific’s specialized team and the enterprise-level comPAS2 software from Vitalograph.
Gareth Morgan, President of Morgan Scientific, said: “Integrating oscillometry into our diagnostics portfolio is a significant advancement for clients whose patients have difficulty with spirometry. We are proud to be the first to offer the compact tremoflo® C2 oscillometer, fully integrated with our existing testing solutions.”
Driving Innovation and Research in Respiratory Health
This collaboration strengthens the foundation for ongoing research and development in oscillometry, enhancing the ability of healthcare professionals to diagnose and monitor lung diseases. The addition of the tremoflo® C2, alongside the tremoflo® C-100 oscillometer, to Vitalograph’s portfolio of diagnostic solutions offers healthcare providers the most comprehensive range of testing options available, supporting a more complete understanding of patient lung health.
About the Partners
For media information:
Laura Colleran
+ 353 (0)89 4727860
SOURCE Vitalograph
NSCEB is launching a 3-month tour of the booming U.S. biotechnology ecosystem RALEIGH, N.C., June…
MDP Completes Acquisition of Significant Ownership Position in NextGen Healthcare and Partners with Thoma Bravo…
New resource helps healthcare providers improve branded communication, ensure HIPAA compliance, and boost patient engagement…
TEMPE, Ariz., June 6, 2025 /PRNewswire/ -- Economic activity in the hospital subsector expanded in…
Open-source leader democratizes enterprise-grade secrets management for fastest-growing startups, Fortune 500 enterprises, and nation-states. SAN…
MIAMI, June 6, 2025 /PRNewswire/ -- Healthy Together, a leading provider of health and human…